Inflammation signals airway smooth muscle cell proliferation in asthma pathogenesis

Multidisciplinary Respiratory Medicine

Volumn 8, Issue 2, 2013, Pages

  Khan, Mohammad Afzal ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Airway inflammation; Airway smooth muscle cells; Asthma

Indexed keywords

CYCLIC AMP; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY REMODELING; AIRWAY SMOOTH MUSCLE CELL; ASTHMA; CELL PROLIFERATION; CHRONIC INFLAMMATION; GENE EXPRESSION; HUMAN; HYPERPLASIA; HYPERTROPHY; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; REVIEW; SMOOTH MUSCLE FIBER; UPREGULATION;

EID: 84876575117     PISSN: 1828695X     EISSN: 20496958     Source Type: Journal    
DOI: 10.1186/2049-6958-8-11     Document Type: Review

References (48)

1. Berman AR, Togias AG, Skloot G, Proud D: Allergen-induced hyperresponsiveness to bradykinin is more pronounced than that to methacholine. J Appl Physiol 1995, 78(5):1844-1852.
2. Skloot G, Permutt S, Togias A: Airway hyperresponsiveness in asthma: a problem of limited smooth muscle relaxation with inspiration. J Clin Invest 1995, 96(5):2393-2403.
3. Postma DS, Kerstjens HA: Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 158(5 Pt 3):S187-S192. (Pubitemid 28536589)
4. Tulic MK, Christodoulopoulos P, Hamid Q: Small airway inflammation in asthma. Respir Res 2001, 2(6):333-339. (Pubitemid 34189661)
5. Barnes PJ, Chung KF, Page CP: Inflammatory mediators of asthma: an update. Pharmacol Rev 1998, 50(4):515-596. (Pubitemid 29028812)
6. Brusasco V, Crimi E, Pellegrino R: Airway hyperresponsiveness in asthma: not just a matter of airway inflammation. Thorax 1998, 53(11):992-998. (Pubitemid 28494343)
7. Barnes PJ: Pharmacology of airway smooth muscle. Am J Respir Crit Care Med 1998, 158(5 Pt 3):S123-S132.
8. Barnes PJ, Lim S: Inhibitory cytokines in asthma. Mol Med Today 1998, 4(10):452-458. (Pubitemid 28464834)
9. Billington CK, Penn RB: Signaling and regulation of G protein-coupled receptors in airway smooth muscle. Respir Res 2003, 4:2.
10. Goncharova EA, Billington CK, Irani C, Vorotnikov AV, Tkachuk VA, Penn RB, Krymskaya VP, Panettieri RA Jr: Cyclic AMP-mobilizing agents and glucocorticoids modulate human smooth muscle cell migration. Am J Respir Cell Mol Biol 2003, 29(1):19-27. (Pubitemid 36783312)
11. Bellucci F, Cucchi P, Santicioli P, Lazzeri M, Turini D, Meini S: Characterization of kinin receptors in human cultured detrusor smooth muscle cells. Br J Pharmacol 2007, 150(2):192-199. (Pubitemid 46160609)
12. Meini S, Cucchi P, Bellucci F, Catalani C, Giuliani S, Santicioli P, Maggi CA: Comparative antagonist pharmacology at the native mouse bradykinin B2 receptor: radioligand binding and smooth muscle contractility studies. Br J Pharmacol 2007, 150(3):313-320. (Pubitemid 46221040)
13. Siehler S: Regulation of RhoGEF proteins by G12/13-coupled receptors. Br J Pharmacol 2009, 158(1):41-49.
14. Hartl D, Lee CG, Da Silva CA, Chupp GL, Elias JA: Novel biomarkers in asthma: chemokines and chitinase-like proteins. Curr Opin Allergy Clin Immunol 2009, 9(1):60-66.
15. Tang H, Shi Z, Xiu Q, Li B, Sun Y: YKL-40-mediated interleukin 8 production may be closely associated with remodeling of bronchial smooth muscle cells. Am J Respir Crit Care Med 2012, 186(4):386. author reply 386-387.
16. Tang H, Sun Y, Shi Z, Huang H, Fang Z, Chen J, Xiu Q, Li B: YKL-40 Induces IL-8 Expression from Bronchial Epithelium via MAPK (JNK and ERK) and NF-kappaB Pathways, Causing Bronchial Smooth Muscle Proliferation and Migration. J Immunol 2012, 190:438-446.
17. Bousquet J: Relating inflammatory changes in asthma to clinical status. Respir Med 2000, 94(F):32-33.
18. Bousquet J: The use of biopsy to study airway inflammation. Respir Med 2000, 94(F):1-2.
19. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM: Asthma From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000, 161(5):1720-1745. (Pubitemid 30329053)
20. Jourdan P, Vendrell JP, Huguet MF, Segondy M, Bousquet J, Pene J, Yssel H: Cytokines and cell surface molecules independently induce CXCR4 expression on CD4+ CCR7+ human memory T cells. J Immunol 2000, 165(2):716-724. (Pubitemid 30484737)
21. Vignola AM, Kips J, Bousquet J: Tissue remodeling as a feature of persistent asthma. J Allergy Clin Immunol 2000, 105(6 Pt 1):1041-1053. (Pubitemid 30418779)
22. Ali H, Panettieri RA Jr: Anaphylatoxin C3a receptors in asthma. Respir Res 2005, 6:19.
23. Ghaffar O, Hamid Q, Renzi PM, Allakhverdi Z, Molet S, Hogg JC, Shore SA, Luster AD, Lamkhioued B: Constitutive and cytokine-stimulated expression of eotaxin by human airway smooth muscle cells. Am J Respir Crit Care Med 1999, 159(6):1933-1942. (Pubitemid 29275066)
24. Laberge S, Pinsonneault S, Ernst P, Olivenstein R, Ghaffar O, Center DM, Hamid Q: Phenotype of IL-16-producing cells in bronchial mucosa: evidence for the human eosinophil and mast cell as cellular sources of IL-16 in asthma. Int Arch Allergy Immunol 1999, 119(2):120 -125.
25. Chung KF, Patel HJ, Fadlon EJ, Rousell J, Haddad EB, Jose PJ, Mitchell J, Belvisi M: Induction of eotaxin expression and release from human airway smooth muscle cells by IL-1beta and TNFalpha: effects of IL-10 and corticosteroids. Br J Pharmacol 1999, 127(5):1145-1150. (Pubitemid 29326637)
26. Lazaar AL, Krymskaya VP, Das SK: VCAM-1 activates phosphatidylinositol 3-kinase and induces p120Cbl phosphorylation in human airway smooth muscle cells. J Immunol 2001, 166(1):155-161. (Pubitemid 32038428)
27. Lazaar AL, Panettieri RA Jr: Airway smooth muscle as an immunomodulatory cell: a new target for pharmacotherapy? Curr Opin Pharmacol 2001, 1(3):259-264. (Pubitemid 33585972)
28. Bousquet J: The relative importance of small airways in asthma. Respir Med 2000, 94(D):1-2.
29. Chung KF, Barnes PJ: Cytokines in asthma. Thorax 1999, 54(9):825-857. (Pubitemid 29401546)
30. Khan MA, Ellis R, Inman MD, Bates JH, Sanderson MJ, Janssen LJ: Influence of airway wall stiffness and parenchymal tethering on the dynamics of bronchoconstriction. Am J Physiol Lung Cell Mol Physiol 2010, 299(1):L98-L108.
31. Khan MA, Kianpour S, Stampfli MR, Janssen LJ: Kinetics of in vitro bronchoconstriction in an elastolytic mouse model of emphysema. Eur Respir J 2007, 30(4):691-700. (Pubitemid 351194829)
32. Wiggs BR, Bosken C, Pare PD, James A, Hogg JC: A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992, 145(6):1251-1258.
33. James AL, Pare PD, Hogg JC: The mechanics of airway narrowing in asthma. Am Rev Respir Dis 1989, 139(1):242-246. (Pubitemid 19030451)
34. Halwani R, Vazquez-Tello A, Sumi Y, Pureza MA, Bahammam A, Al-Jahdali H, Soussi-Gounni A, Mahboub B, Al-Muhsen S, Hamid Q: Eosinophils Induce Airway Smooth Muscle Cell Proliferation. J Clin Immunol 2012,
35. Imaoka H, Campbell H, Babirad I, Watson RM, Mistry M, Sehmi R, Gauvreau GM: TPI ASM8 reduces eosinophil progenitors in sputum after allergen challenge. Clin Exp Allergy 2011, 41(12):1740-1746.
36. Incorvaia C, Mauro M, Riario-Sforza GG, Frati F, Tarantini F, Caserini M: Current and future applications of the anti-IgE antibody omalizumab. Biologics 2008, 2(1):67-73.
37. Incorvaia C, Pravettoni C, Mauro M, Yacoub MR, Tarantini F, Riario-Sforza GG: Effectiveness of omalizumab in a patient with severe asthma and atopic dermatitis. Monaldi Arch Chest Dis 2008, 69(2):78-80.
38. Tarantini F, Baiardini I, Passalacqua G, Braido F, Canonica GW: Asthma treatment: 'magic bullets which seek their own targets'. Allergy 2007, 62(6):605-610. (Pubitemid 46763449)
39. Hanania NA: Targeting airway inflammation in asthma: current and future therapies. Chest 2008, 133(4):989-998.
40. Hanania NA, Mannava B, Franklin AE, Lipworth BJ, Williamson PA, Garner WJ, Dickey BF, Bond RA: Response to salbutamol in patients with mild asthma treated with nadolol. Eur Respir J 2010, 36(4):963-965.
41. Berger WE: New approaches to managing asthma: a US perspective. Ther Clin Risk Manag 2008, 4(2):363-379.
42. Mustafa SJ, Nadeem A, Fan M, Zhong H, Belardinelli L, Zeng D: Effect of a specific and selective A(2B) adenosine receptor antagonist on adenosine agonist AMP and allergen-induced airway responsiveness and cellular influx in a mouse model of asthma. J Pharmacol Exp Ther 2007, 320(3):1246-1251. (Pubitemid 46294058)
43. Feoktistov I, Biaggioni I: Adenosine A2B receptors. Pharmacol Rev 1997, 49(4):381-402.
44. Adcock IM, Caramori G: Chemokine receptor inhibitors as a novel option in treatment of asthma. Curr Drug Targets Inflamm Allergy 2004, 3(3):257-261. (Pubitemid 39206653)
45. Lloyd CM, Brown Z: Chemokine receptors: therapeutic potential in asthma. Treat Respir Med 2006, 5(3):159-166.
46. Dickey BF, Walker JK, Hanania NA, Bond RA: beta-Adrenoceptor inverse agonists in asthma. Curr Opin Pharmacol 2010, 10(3):254-259.
47. Hanaoka M, Nicolls MR, Fontenot AP, Kraskauskas D, Mack DG, Kratzer A, Salys J, Kraskauskiene V, Burns N, Voelkel NF, Taraseviciene-Stewart L: Immunomodulatory strategies prevent the development of autoimmune emphysema. Respir Res 2010, 11:179.
48. Sharafkhaneh A, Mattewal AS, Abraham VM, Dronavalli G, Hanania NA: Budesonide/formoterol combination in COPD: a US perspective. Int J Chron Obstruct Pulmon Dis 2010, 5:357-366.